HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, C. C. Articles by Yamada, K. M. Search for Related Content PubMed PubMed Citation Articles by Lee, C. C. Articles by Yamada, K. M. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 269, Issue 30, 19457-19461, Jul, 1994

Identification of a novel type of alternative splicing of a tyrosine kinase receptor. Juxtamembrane deletion of the c-met protein kinase C serine phosphorylation regulatory site

CC Lee and KM Yamada
Laboratory of Developmental Biology, NIDR, National Institutes of Health, Bethesda, Maryland 20892.

We have detected a novel type of structural variant of the tyrosine kinase receptor for c-met, also known as the hepatocyte growth factor receptor, in mouse tissues. The cDNA of the variant transcript of c-met lacks 141 base pairs, which predicts an in-frame deletion of 47 amino acids in the juxtamembrane region of the cytoplasmic domain. Sequence analysis of genomic DNA containing the c-met locus revealed that the absence of a discrete exon is responsible for this 141-base pair deletion and that alternative splicing leads to production of two forms of transcript. These two forms of transcript are designated as c-metsm (for small) and c-metlg (for large) to distinguish the absence or presence of the 141-base pair segment, respectively. The c-metsm variant is present in adult mouse tissues including kidney, liver, and brain as well as in 9-10-day-old embryos. In all cases, expression of c- metsm was lower than that of the normal transcript, c-metlg. An antiserum against mouse c-Met protein immunoprecipitated corresponding protein forms of approximately 152 and approximately 145 kDa from whole kidney lysate under reducing conditions. The size difference of approximately 7 kDa between these isoforms corresponds to the predicted difference of 47 amino acids. The presence of this shorter variant transcript and its corresponding protein isoform in a variety of normal tissues suggests a physiological role. The deleted region in the cytoplasmic domain of c-metsm contains a sequence motif (S985ARS) for protein kinase C phosphorylation that has recently been shown to play a key role in the down-regulation of hepatocyte growth factor receptor kinase activity. The identification of this novel isoform, c-metsm, demonstrates that a tyrosine kinase receptor can achieve additional diversity by alternative splicing at a key regulatory site in its cytoplasmic domain.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Hashigasako, M. Machide, T. Nakamura, K. Matsumoto, and T. Nakamura Bi-directional Regulation of Ser-985 Phosphorylation of c-Met via Protein Kinase C and Protein Phosphatase 2A Involves c-Met Activation and Cellular Responsiveness to Hepatocyte Growth Factor J. Biol. Chem., June 18, 2004; 279(25): 26445 - 26452. [Abstract] [Full Text] [PDF]

				P. C. Ma, T. Kijima, G. Maulik, E. A. Fox, M. Sattler, J. D. Griffin, B. E. Johnson, and R. Salgia c-MET Mutational Analysis in Small Cell Lung Cancer: Novel Juxtamembrane Domain Mutations Regulating Cytoskeletal Functions Cancer Res., October 1, 2003; 63(19): 6272 - 6281. [Abstract] [Full Text] [PDF]

				M.-H. Wang, A. L. Kurtz, and Y.-Q. Chen Identification of a novel splicing product of the RON receptor tyrosine kinase in human colorectal carcinoma cells Carcinogenesis, August 1, 2000; 21(8): 1507 - 1512. [Abstract] [Full Text] [PDF]

				F. Blanquaert, R. C. Pereira, and E. Canalis Cortisol inhibits hepatocyte growth factor/scatter factor expression and induces c-met transcripts in osteoblasts Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E509 - E515. [Abstract] [Full Text] [PDF]

				F. Blanquaert, A. M. Delany, and E. Canalis Fibroblast Growth Factor-2 Induces Hepatocyte Growth Factor/Scatter Factor Expression in Osteoblasts Endocrinology, March 1, 1999; 140(3): 1069 - 1074. [Abstract] [Full Text]

				Y. Wen, J. L. Edelman, T. Kang, N. Zeng, and G. Sachs Two Functional Forms of Vascular Endothelial Growth Factor Receptor-2/Flk-1 mRNA Are Expressed in Normal Rat Retina J. Biol. Chem., January 23, 1998; 273(4): 2090 - 2097. [Abstract] [Full Text] [PDF]

				C. Webb, K Lane, A. Dawson, G. Vande Woude, and R. Warn C-Met signalling in an HGF/SF-insensitive variant MDCK cell line with constitutive motile/invasive behaviour J. Cell Sci., January 9, 1996; 109(9): 2371 - 2381. [Abstract] [PDF]

				C.-C. Lee and K. M. Yamada Alternatively Spliced Juxtamembrane Domain of a Tyrosine Kinase Receptor Is a Multifunctional Regulatory Site J. Biol. Chem., January 13, 1995; 270(2): 507 - 510. [Abstract] [Full Text] [PDF]

				B Niranjan, L Buluwela, J Yant, N Perusinghe, A Atherton, D Phippard, T Dale, B Gusterson, and T Kamalati HGF/SF: a potent cytokine for mammary growth, morphogenesis and development Development, January 9, 1995; 121(9): 2897 - 2908. [Abstract] [PDF]

				M. Machide, K. Kamitori, and S. Kohsaka Hepatocyte Growth Factor-induced Differential Activation of Phospholipase Cgamma 1 and Phosphatidylinositol 3-Kinase Is Regulated by Tyrosine Phosphatase SHP-1 in Astrocytes J. Biol. Chem., September 29, 2000; 275(40): 31392 - 31398. [Abstract] [Full Text] [PDF]